Welcome to LookChem.com Sign In|Join Free
The company logo of Chemvon Biotechnology Co. Ltd.

Chemvon Biotechnology Co. Ltd.

Assessed Supplier Enterprise Certification

Assessed
Supplier
17th
years

Chemvon Biotechnology Co. Ltd.

Business Type:Lab/Research institutions

Audited Supplier

Main Products:
Atocalcitol ,Inecalcitol,Alvimopan ,Fosaprepitant, Bimatoprost,Lubiprostone,Tafluprost
Year Established:
2008
Home>>Products>>Tecovirimat

Product Certification&
Enterprise Certification

More Detail

Chemvon Biotechnology Co. Ltd.

Country: China (Mainland)

Business Type:Lab/Research institutions

Mr.peter

Tel: 86-21-58550039;86-21-31268550-8004

Mobile:

Tel: 86-21-58550039;86-21-31268550-8004

Fax: 86-21-50790419

URL: http://www.chemvon.com

Province/state: shanghai

City: shanghai

Street: Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China

MaxCard:


Contact Suppliers

Tecovirimat

CAS NO.816458-31-8

  • Min.Order: 0 Metric Ton
  • Payment Terms:
Contact Supplier

Product Details

Keywords

  • Tecovirimat manufacturer
  • 98% Tecovirimat

Quick Details

  • ProName: Tecovirimat
  • CasNo: 816458-31-8
  • PackAge: 1g, 10g, 100g, 200g, 1kg, 5kg
  • Port: any port in China
  • ProductionCapacity: Metric Ton/Day
  • Purity: 98%
  • LimitNum: 0 Metric Ton
  • Grade: Pharma Grade

Superiority

Chemvon Biotechnology is one of the leading high-technology manufacturer in the field of pharmaceutical and fine chemical industry.

From origins as a research group in technology service, chemvon has progressed into an integrated company with a kilo lab and a pilot plant offering a range of APIs, NCEs and some organic intermediates.

Quality: Adopting the leading technology to assure the high quality.

Price: Offering the best price among the suppliers in China.

Rich material and energe make us control the cost effective

Afrer-sale service: Chemvon will take charge of everthing if there is any question after the sale.

Certificates: We can offer ISO9001 certificates that you need for importing.

 

Details

Tecovirimat (ST-246) is an antiviral with activity against orthopoxviruses such as smallpox and is currently undergoing clinical trials. It was previously owned by Viropharma and discovered in collaboration with scientists at USAMRIID. It is currently owned and is synthesized by SIGA Technologies, a drug development company in the biodefense arena. It works by blocking cellular transmission of the virus, thus preventing the disease. Tecovirimat has been effective in laboratory testing, with no serious side effects reported to date.